{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:55:54Z","timestamp":1763686554248,"version":"3.40.2"},"reference-count":6,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2024,10,18]]},"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1136\/jnnp-2024-334584","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T18:20:24Z","timestamp":1736619624000},"page":"309-309","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["C5 complement inhibition and FcRn modulation in generalized myasthenia gravis. Fast-acting but short-lived therapies the use of which should prompt assertive escalation of conventional treatments"],"prefix":"10.1136","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6788-0642","authenticated-orcid":false,"given":"John","family":"McConville","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,1,11]]},"reference":[{"key":"2025032404000917000_96.4.309.1","first-page":"310","article-title":"C5 complement inhibition versus FcRn modulation in generalized myasthenia gravis","volume":"96","author":"Huntemann","year":"2025","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2025032404000917000_96.4.309.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602489"},{"key":"2025032404000917000_96.4.309.3","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2022.2887"},{"key":"2025032404000917000_96.4.309.4","doi-asserted-by":"publisher","DOI":"10.1111\/cen3.12739"},{"key":"2025032404000917000_96.4.309.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901213400311"},{"key":"2025032404000917000_96.4.309.6","unstructured":"vanDoorn IN , Bus SRM , Zambreanu L , et al . OPTIC Trial: Intravenous Immunoglobulin And Intravenous Methylprednisolone As Induction Treatment In CIDP. Abstract O436 in Richard A.C. Hughes Symposium - Clinical Highlights.Montr\u00e9al. Peripheral Nerve Society 2024."}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2024-334584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T11:06:33Z","timestamp":1742814393000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2024-334584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,11]]},"references-count":6,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,3,24]]},"published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1136\/jnnp-2024-334584"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2024-334584","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"type":"print","value":"0022-3050"},{"type":"electronic","value":"1468-330X"}],"subject":[],"published":{"date-parts":[[2025,1,11]]}}}